regenerative medicine
Stem Cells and Regenerative Medicine - An Interview with Stephen Minger
October 04 by Gerald ClarkeAs part of our Future Pharma Series, we spoke to Dr. Stephen Minger, Chief Scientist, Research and Applied Markets at Life Sciences, GE Healthcare about the future of regenerative medicine. As he si...
Despite Advances in Technology, Regenerative Medicine Field Still Faces Great Hurdles on the Road to Commercialization
November 17 by Pharma IQ NewsIQPC’s Commercialization of Regenerative Medicine Conference focuses on surmounting challenges faced by the industry PHILADELPHIA, PA – Pharma IQ, a division of IQPC, announces the Co...
Scale-Up and Manufacturing of Regenerative Medicine
September 28 by Amber ScorahWhen introducing a regenerative medicine cell based product to a commercial setting, there are a number of things to take into consideration to ensure a commercially viable and safe product for patien...
The Future Potential of Human Limb Regeneration
September 20 by Amy PatelLimb regeneration in humans seems like such a foreign concept, yet invertebrates such as starfish, worms, sponges, and hydra have the ability to regenerate missing tails, legs, and some species even...
Commercialisation of Regenerative Medicine
September 20 by Pharma IQRegenerative medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to damage, or congenital defects. This field holds the promise of r...
Solving the Challenges of Stem Cell Tissues
August 19 by Amy PatelEveryone has heard buzz around stem cell research, artificial organs and tissue engineering, and now becoming educated on the politics and science of these topics is increasingly important. Thes...
Stem Cells and Regenerative Medicine - An Interview with Stephen Minger
March 29 by Stephen MingerGerald Clarke: I'm Gerald Clarke, Editor of Pharma IQ. Today I'm joined by Doctor Stephen Minger, Chief Scientist, Research and Applied Markets at...
Scale-Up and Manufacturing of Regenerative Medicine
March 29 by William FodorWhen introducing a regenerative medicine cell based product to a commercial setting, there are a number of things to take into consideration to ensure a commercially viable and safe product for patien...